Reticular Analysis
What is Reticular?
Reticular helps IVF patients evaluate embryos using existing genetic data and a partner at-home test. The company says it provides best-in-class genomic analysis, embryo risk scoring, and genetic counseling for embryo selection. It also states its research is peer-reviewed, published, and open to scrutiny.
Location
San Francisco, California, United States
Employees
1-10
Founded
2024
Investors
- Y Combinator
Product Features & Capabilities
- mechanistic understanding for biological AI systems, interpretability techniques for biological sequence models, sample-efficient guidance algorithms for protein engineering, reliable model steering with limited validation data, safeguards built into model capabilities
Who are the founders of Reticular
NP
Nithin Parsan
Founder
JY
John Yang
Founder
Market Focus
Reticular primarily focuses on the biotechnology and artificial intelligence industries, specifically in developing biological AI systems and mechanistic understanding to enhance model reliability and accelerate development.
Competitors Overview
The main competitors of Reticular in the biological AI systems and protein engineering market include:
-
Antiverse: This company utilizes in silico models for antibody discovery, focusing on computational methods to enhance the efficiency of antibody development. Their approach may differ from Reticular's mechanistic understanding by emphasizing computational modeling over biological interpretation.
-
Nabla Bio: An AI-driven company specializing in antibody design, Nabla Bio leverages machine learning to optimize antibody properties. Their focus on AI for design contrasts with Reticular's emphasis on mechanistic understanding and interpretability.
-
Generate Biosciences: This company pioneers machine learning applications in drug generation, which may provide a broader scope in drug discovery compared to Reticular's specific focus on protein engineering.
-
Tender: While primarily focused on plant-based meat alternatives, Tender's innovations in biotechnology may overlap with Reticular's market, particularly in the application of biological systems.
-
Tonix Pharmaceuticals: A biopharmaceutical company developing drugs and biologics, Tonix's work in drug development may intersect with Reticular's goals in protein engineering, although their primary focus is on pharmaceuticals rather than AI systems.
These competitors highlight a range of approaches within the protein engineering and biological AI landscape, with notable differences in their methodologies and areas of focus.
See something that needs updating? Suggest edits to this profile.